Michael Konstan talks breakthrough treatment for cystic fibrosis

Breakthrough drug announced for cystic fibrosis treatment

The Plain Dealer: For the first time, a new oral drug has been shown to work on a genetic defect that causes cystic fibrosis rather than the disease’s symptoms, said Michael W. Konstan, professor of pediatrics at the School of Medicine. “The study shows that this drug can safely provide long-term benefits for patients,” he said.